Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/45904
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZarb, Peter-
dc.contributor.authorCoignard, Bruno P.-
dc.contributor.authorGriškevičiene, Jolanta-
dc.contributor.authorMuller, Arno A.-
dc.contributor.authorVankerckhoven, Vanessa V. J.-
dc.contributor.authorWeist, K.-
dc.contributor.authorGoossens, Mathijs Michiel-
dc.contributor.authorVaerenberg, Sofie-
dc.contributor.authorHopkins, Susan M.-
dc.contributor.authorCatry, Boudewijn-
dc.contributor.authorMonnet, Dominique Louis-
dc.contributor.authorGoossens, Herman J.-
dc.contributor.authorSuetens, Carl-
dc.date.accessioned2019-08-26T08:48:56Z-
dc.date.available2019-08-26T08:48:56Z-
dc.date.issued2012-
dc.identifier.citationZarb, P., Coignard, B., Griskeviciene, J., Muller, A., Vankerckhoven, V., Weist, K.,...Suetens, C. (2012). The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Eurosurveillance, 17(46), 1-16.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/45904-
dc.description.abstractA standardised methodology for a combined point prevalence survey (PPS) on healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospitals developed by the European Centre for Disease Prevention and Control was piloted across Europe. Variables were collected at national, hospital and patient level in 66 hospitals from 23 countries. A patient-based and a unit-based protocol were available. Feasibility was assessed via national and hospital questionnaires. Of 19,888 surveyed patients, 7.1% had an HAI and 34.6% were receiving at least one antimicrobial agent. Prevalence results were highest in intensive care units, with 28.1% patients with HAI, and 61.4% patients with antimicrobial use. Pneumonia and other lower respiratory tract infections (2.0% of patients; 95% confidence interval (CI): 1.8-2.2%) represented the most common type (25.7%) of HAI. Surgical prophylaxis was the indication for 17.3% of used antimicrobials and exceeded one day in 60.7% of cases. Risk factors in the patient-based protocol were provided for 98% or more of the included patients and all were independently associated with both presence of HAI and receiving an antimicrobial agent. The patient-based protocol required more work than the unit-based protocol, but allowed collecting detailed data and analysis of risk factors for HAI and antimicrobial use.en_GB
dc.language.isoenen_GB
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)en_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectInfectious disease and therapy -- Research -- Europeen_GB
dc.subjectAnti-infective agents -- Case studies -- Europeen_GB
dc.subjectNosocomial infections -- Research -- Europeen_GB
dc.subjectCommunicable diseases -- Europe -- Epidemiology -- Statisticsen_GB
dc.subjectCommunicable diseases -- Europe -- Statisticsen_GB
dc.titleThe European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial useen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.2807/ese.17.46.20316-en-
dc.publication.titleEurosurveillanceen_GB
Appears in Collections:Scholarly Works - FacM&SPat



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.